Platinum Add-On Improves Survival in Early TNBC

Source link :

CHICAGO — Adding carboplatin to standard anthracycline/taxane treatment for early-stage triple-negative breast cancer (TNBC) improves event-free and overall survival in the neoadjuvant and adjuvant setting, according to a phase 3 trial presented on June 3 at the American Society of Clinical Oncology (ASCO) 2024 annual meeting. The event-free survival benefit reached statistical significance (P = .012), […]

Author : News Health

Publish date : 2024-06-25 11:52:03

Copyright for syndicated content belongs to the linked Source.